Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Gareau

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Acta Physiologica Scandinavica|September 1, 1999
Effects of recombinant erythropoietin (r-HuEPO) on plasma glucose concentration in endurance-trained ratsJ Cayla, C Lavoie, R Gareau, et al.
The Journal of Biological Chemistry|December 24, 2011
Determinants of small ubiquitin-like modifier 1 (SUMO1) protein specificity, E3 ligase, and SUMO-RanGAP1 binding activities of nucleoporin RanBP2Jaclyn R Gareau, David Reverter, Christopher D Lima
International Journal of Sports Medicine|July 10, 1998
Erythropoietin (rHuEPO) doping: effects of exercise on anaerobic metabolism in ratsC Lavoie, A Diguet, M Milot, et al.
L'Union Medicale Du Canada|April 1, 1974
[Pseudolymphomatous gastritis (pseudolymphoma of the stomach): anatomo-radiological correlation]K Meagher-Villemure, R Gareau, H P Lévesque
Cellular and Molecular Biology|July 1, 1992
Blood banking-induced senescent modifications on red blood cellsR Gareau, G R Brisson, H Goulet, et al.
Biotechniques|August 25, 2005
Low-cost modification to the Copacabana method for spreading transformation mixturesKenneth V Mills, Jaclyn R Gareau, Alicia M Garcia
Canadian Journal of Physiology and Pharmacology|October 1, 1992
Acute administration of bromocriptine abolishes the hyperprolactinemic response induced by submaximal exercise in manP Boisvert, G R Brisson, F Péronnet, et al.
Biopharmaceutics & Drug Disposition|December 1, 1996
Pharmacokinetics and haematological parameters of recombinant human erythropoietin after subcutaneous administrations in horsesA Souillard, M Audran, F Bressolle, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|August 1, 1992
Modification of RBC properties by an autoantibody. Binding to RBC senescent antigenR Gareau, G R Brisson, J Dubé, et al.
Journal of Pharmacokinetics and Biopharmaceutics|June 1, 1997
Comparison of a direct and indirect population pharmacodynamic model: application to recombinant human erythropoietin in athletesF Bressolle, M Audran, R Gareau, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Acta Physiologica Scandinavica|September 1, 1999
Effects of recombinant erythropoietin (r-HuEPO) on plasma glucose concentration in endurance-trained ratsJ Cayla, C Lavoie, R Gareau, et al.
The Journal of Biological Chemistry|December 24, 2011
Determinants of small ubiquitin-like modifier 1 (SUMO1) protein specificity, E3 ligase, and SUMO-RanGAP1 binding activities of nucleoporin RanBP2Jaclyn R Gareau, David Reverter, Christopher D Lima
International Journal of Sports Medicine|July 10, 1998
Erythropoietin (rHuEPO) doping: effects of exercise on anaerobic metabolism in ratsC Lavoie, A Diguet, M Milot, et al.
L'Union Medicale Du Canada|April 1, 1974
[Pseudolymphomatous gastritis (pseudolymphoma of the stomach): anatomo-radiological correlation]K Meagher-Villemure, R Gareau, H P Lévesque
Cellular and Molecular Biology|July 1, 1992
Blood banking-induced senescent modifications on red blood cellsR Gareau, G R Brisson, H Goulet, et al.
Biotechniques|August 25, 2005
Low-cost modification to the Copacabana method for spreading transformation mixturesKenneth V Mills, Jaclyn R Gareau, Alicia M Garcia
Canadian Journal of Physiology and Pharmacology|October 1, 1992
Acute administration of bromocriptine abolishes the hyperprolactinemic response induced by submaximal exercise in manP Boisvert, G R Brisson, F Péronnet, et al.
Biopharmaceutics & Drug Disposition|December 1, 1996
Pharmacokinetics and haematological parameters of recombinant human erythropoietin after subcutaneous administrations in horsesA Souillard, M Audran, F Bressolle, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|August 1, 1992
Modification of RBC properties by an autoantibody. Binding to RBC senescent antigenR Gareau, G R Brisson, J Dubé, et al.
Journal of Pharmacokinetics and Biopharmaceutics|June 1, 1997
Comparison of a direct and indirect population pharmacodynamic model: application to recombinant human erythropoietin in athletesF Bressolle, M Audran, R Gareau, et al.
Pageof 6